Related Experiment Video
Updated: May 2, 2026

Rodent Model of Intestinal Ischemia-Reperfusion Injury via Occlusion of the Superior Mesenteric Artery
Published on: October 20, 2023
Medical, Surgical and Experimental Approaches to Acute Mesenteric Ischemia and Reperfusion
Zoran Matkovic1, Zoran Aleksic2,3
1Department of Abdominal Surgery, General Hospital Doboj. Doboj, Bosnia and Herzegovina.
Background:
Acute mesenteric ishemia(AMI) is a rare but very serious disease with high rate of mortality and morbidity. About 1-2% of all gastrointestinal disease is AMI. Mortality is about 60-80% and depends of time between starting of symptoms and establishing of diagnosis, type AMI, comorbidities. AMI is often in older population with coronary syndrom and atrial fibrilation. AMI may be occlusive(embolisatio arteriae mesentericae superior(AMS), or thrombosis of AMS, mesenterial vein thrombosis) and nonoclusive form(NOMI). NOMI is rising in critical ill patients in shock or sepsis. Pathophysiology of AMI is very complex and significant role in this proces has ischemia and also reperfusion. Reperfusion injury including oxidative stres, inflamation, infection. The best diagnostic approach is CT angiography but after high clinical suspicion on AMI. Patients have sudden, catastrophic abdominal pain, vomitus, bloody diarrhoea. Therapy is multidisciplinary-basic treatment(resuscitation with cristaloids, antibiotic, anticoagulans...), surgical treatment-resection necrotic segments of intestinum without anastomosis or endovascular treatment. In early phases conservative treatment is possible( vasodilatation, thrombolysis). In some countries there are Intestinal Stroke Centers (ISC) in which patients with AMI have better prognosis. Because of progressive nature of AMI( rapide worsening) rare are clinical study,but there are many experimental study on animal models. Most of experimental study investigate protective effects of some supstances on damage on intestinum and remote organs during ishemia and reperfusion.
Objective:
To present literature data of clinical and experimental study, describe experiments on animal models and mention supstances whit promising results in protective strategies during AMI.
Methods:
We analysed Pubmed by using mesh terms such as acute mesenteric ischemia, intestinal injury, reperfusion, experimental study, clinical and therapeutic approach. Results: Sudden abdominal pain resists on opioids analgetics, high rate of CRP, hyperlactatemia, increase of D dimer is enough for suspicion of AMI. Often is delayed in establishing of diagnosis of AMI. CT angiography has sensitivity of 94%. Pneumatosis is sign of necrosis of intestinal wall. Classical surgical approach is dominant, more than 70%,. Endovascular treatment became often last few years. Experimental studies investigate occlusion of AMS with atraumatic clamp, with schemia and reperfusion in different intervals Most animals models are on wistar male rats.
Conclusion:
AMI has still high rate of mortality. Better diagnostic and therapeutic principles (shorter interval between appearance of symptoms and starting of therapy, multidisciplinary approach, higher percent of endovascular procedures), could decrease mortality. Experimental studies on animal models may be succesfull in development of new clinical, conservative approaches in the early phases of AMI in the future.
Insights
Acute mesenteric ischemia (AMI) is a severe condition with high mortality. Early diagnosis and multidisciplinary treatment, including endovascular procedures, can improve outcomes for AMI patients.
Area of Science:
- Gastroenterology
- Vascular Surgery
- Emergency Medicine
Background:
- Acute mesenteric ischemia (AMI) is a rare gastrointestinal emergency with high mortality (60-80%), often affecting older individuals with comorbidities.
- It can be occlusive (e.g., superior mesenteric artery embolism/thrombosis) or non-occlusive (NOMI), particularly in critically ill patients.
- Pathophysiology involves complex ischemia-reperfusion injury, including oxidative stress and inflammation.
Purpose of the Study:
- To review literature on clinical and experimental studies of AMI.
- To describe animal models used in AMI research.
- To highlight substances with potential protective effects in AMI treatment strategies.
Main Methods:
- Literature search using PubMed with terms like 'acute mesenteric ischemia,' 'intestinal injury,' and 'reperfusion.'
- Analysis of clinical data including diagnostic indicators (pain, CRP, lactate, D-dimer) and imaging (CT angiography sensitivity 94%).
- Review of treatment approaches, noting dominance of surgical resection (>70%) and increasing endovascular interventions, alongside experimental models (Wistar rats).
Main Results:
- AMI diagnosis is often delayed, despite characteristic symptoms and elevated biomarkers.
- CT angiography is crucial for diagnosis, with pneumatosis indicating intestinal necrosis.
- Surgical intervention remains dominant, but endovascular treatments are gaining traction.
Conclusions:
- Reducing AMI mortality requires improved diagnostics, timely multidisciplinary therapy, and increased endovascular procedures.
- Experimental studies on animal models hold promise for developing novel conservative treatments for early-stage AMI.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Kidney Transplant II: Surgical Procedure

